Menu

Skin-Eating Fungus Threatens Salamanders

A fungus that erodes the skin has caused massive die-offs of fire salamanders in the Netherlands.

Sep 3, 2013
Chris Palmer

WIKIMEDIA, DIDIER DESCOUENSA close relative of the chytrid fungus Batrachochytrium dendrobatidis (Bd)thought to have wiped out more than 200 amphibian species since the 1980shas been found responsible for decimating the fire salamander population in the Netherlands over the past five years. The findings were published Monday (September 2) in Proceedings of the National Academy of Sciences.

The newly discovered fungus, Batrachochytrium salamandrivorans, or Bs, specifically targets salamanders. It eats through the skin, exposing the creatures to deadly bacteria and viruses. “It causes ulceration and holes in the skin and kills within just 12 days,” An Martel, a biologist at Ghent University in Belgium, told New Scientist.

Once Martel and her colleagues grasped the magnitude of the die-offs, they captured 39 surviving salamanders from affected areas in order to breed them in the lab. At one point, the lab-raised population dwindled to 10 individuals, but offspring may soon be released into the wild.

Though Bd and Bs are closely related, Bs is genetically different enough from Bd that previous surveillance programs for Bd would have missed Bs, co-author Matthew Fisher, a fungal epidemiologist at Imperial College London, told New Scientist. Also, unlike Bd, it appears that the Bs fungus does not affect toads and frogs.

“Our experience with Bd has shown that fungal diseases can spread between amphibian populations across the world very quickly,” Fisher said in a statement. “We need to act urgently to determine what populations are in danger and how best to protect them.”

Martel’s team has developed a DNA-based test for Bs and encourages researchers around the world to screen amphibians for the fungus. The researchers are also trying to determine whether Bs spreads via contact, as early experiments suggest, or whether it spreads via airborne spores, as does Bd.

Treatment with voriconazole, an antifungal medication often used by humans, has shown some promise.

Matthew Niemiller, a biologist at Yale University who studies salamanders but was not involved in the work, told New Scientist that no mass die-offs have so far been observed in North America. “I imagine that in the next six months we’ll have a better picture of how widespread this fungus is, whether it’s just Europe, or more widely spread,” he said.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.